Index S&P 500
P/E 11.03
EPS (ttm) 17.71
Insider Own 0.72%
Shs Outstand 39.62M
Perf Week -0.02%
Market Cap 7.64B
Forward P/E 12.76
EPS next Y 15.30
Insider Trans 0.05%
Shs Float 38.85M
Perf Month -23.71%
Income 701.00M
PEG 1.50
EPS next Q 3.27
Inst Own 93.48%
Short Float 2.16%
Perf Quarter -28.86%
Sales 11.71B
P/S 0.65
EPS this Y -17.50%
Inst Trans 2.18%
Short Ratio 1.94
Perf Half Y -22.77%
Book/sh 107.41
P/B 1.82
EPS next Y 8.65%
ROA 6.46%
Short Interest 0.84M
Perf Year -18.38%
Cash/sh 0.26
P/C 764.20
EPS next 5Y 7.36%
ROE 17.67%
52W Range 184.29 - 299.50
Perf YTD -24.78%
Dividend Est. 4.33 (2.22%)
P/FCF 41.76
EPS past 5Y -2.21%
ROI 11.44%
52W High -34.79%
Beta 0.54
Dividend TTM 5.20 (2.66%)
Quick Ratio 0.73
Sales past 5Y 7.03%
Gross Margin 13.84%
52W Low 5.97%
ATR (14) 7.10
Dividend Ex-Date Nov 29, 2024
Current Ratio 0.79
EPS Y/Y TTM 33.51%
Oper. Margin 4.87%
RSI (14) 33.79
Volatility 2.44% 3.41%
Employees 44000
Debt/Eq 0.67
Sales Y/Y TTM 5.58%
Profit Margin 5.99%
Recom 2.94
Target Price 211.64
Option/Short Yes / Yes
LT Debt/Eq 0.46
EPS Q/Q -30.89%
Payout 29.41%
Rel Volume 1.32
Prev Close 190.25
Sales Surprise -4.06%
EPS Surprise -33.59%
Sales Q/Q -2.38%
Earnings Oct 31 BMO
Avg Volume 432.87K
Price 195.30
SMA20 -5.95%
SMA50 -18.49%
SMA200 -25.18%
Trades
Volume 564,260
Change 2.65%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-01-24 Downgrade
TD Cowen
Buy → Hold
$180
Nov-01-24 Downgrade
Alembic Global Advisors
Overweight → Neutral
$210
Oct-10-24 Downgrade
Wolfe Research
Outperform → Peer Perform
Oct-10-24 Downgrade
Vertical Research
Buy → Hold
$275
Sep-09-24 Downgrade
JP Morgan
Overweight → Neutral
$280 → $285
May-20-24 Initiated
Citigroup
Buy
$310
Jan-05-24 Downgrade
Barclays
Overweight → Equal Weight
$250 → $280
Sep-28-23 Upgrade
JP Morgan
Neutral → Overweight
$250 → $247
Sep-28-23 Initiated
Deutsche Bank
Hold
$217
Dec-08-22 Upgrade
Barclays
Equal Weight → Overweight
$270
Nov-11-22 Downgrade
BofA Securities
Neutral → Underperform
$230
Oct-12-22 Initiated
Credit Suisse
Neutral
$245
Oct-11-22 Initiated
Wolfe Research
Outperform
$315
Apr-14-22 Upgrade
Cowen
Market Perform → Outperform
$200 → $270
Mar-17-22 Upgrade
Vertical Research
Hold → Buy
$250
Dec-15-21 Initiated
Wolfe Research
Outperform
$225
Nov-11-21 Downgrade
BofA Securities
Buy → Neutral
$240 → $215
Jan-06-21 Downgrade
Vertical Research
Buy → Hold
$177
Dec-04-20 Upgrade
Alembic Global Advisors
Neutral → Overweight
$199
May-22-20 Upgrade
Stifel
Sell → Hold
$230 → $190
Show Previous Ratings
Nov-21-24 04:30PM
07:00AM
Nov-20-24 05:00PM
04:52AM
Nov-19-24 03:00PM
01:15PM
Loading…
01:15PM
Nov-14-24 11:45PM
08:42AM
06:40AM
Nov-13-24 02:00PM
05:44AM
Nov-12-24 04:31AM
Nov-06-24 02:00PM
08:35AM
Nov-01-24 03:30PM
02:57PM
Loading…
02:57PM
08:21AM
03:10AM
Oct-31-24 05:46PM
(Morningstar Research) -26.16%
05:05PM
03:42PM
12:06PM
(The Wall Street Journal)
11:30AM
09:30AM
08:30AM
08:25AM
07:21AM
(Associated Press Finance)
07:15AM
Oct-30-24 08:15AM
03:10AM
03:30PM
Loading…
Oct-28-24 03:30PM
Oct-25-24 10:00AM
Oct-24-24 10:01AM
Oct-16-24 03:00PM
Oct-14-24 08:32AM
Oct-11-24 11:30AM
Oct-09-24 02:30PM
12:00PM
Oct-08-24 12:15PM
Oct-05-24 04:15PM
08:08AM
Oct-04-24 03:15PM
10:45AM
Oct-03-24 11:30AM
10:00AM
Oct-02-24 02:30PM
09:42AM
Oct-01-24 11:00AM
Sep-24-24 06:15PM
04:53AM
Sep-20-24 11:30AM
Sep-09-24 10:00AM
Sep-06-24 05:00PM
Aug-28-24 04:30PM
Aug-22-24 08:45PM
Aug-16-24 03:55AM
Aug-15-24 10:00AM
04:15AM
Aug-12-24 10:00AM
Aug-07-24 05:30PM
Aug-05-24 10:00AM
Aug-02-24 01:09AM
Aug-01-24 05:30PM
04:50PM
09:30AM
09:18AM
08:25AM
07:54AM
07:32AM
(Associated Press Finance)
07:15AM
Jul-31-24 09:40AM
09:15AM
Jul-30-24 08:15AM
Jul-26-24 11:29AM
Jul-25-24 10:02AM
06:00AM
Jul-23-24 10:00AM
Jul-18-24 10:00AM
Jul-16-24 06:24PM
12:10PM
Jul-15-24 04:30PM
09:02AM
Jul-10-24 06:00PM
09:40AM
Jul-03-24 10:00AM
Jul-01-24 05:22AM
Jun-28-24 02:00PM
06:00AM
Jun-26-24 04:45PM
Jun-25-24 05:15PM
Jun-17-24 11:30AM
Jun-03-24 05:30PM
10:57AM
Jun-01-24 07:07AM
May-31-24 03:15PM
May-29-24 03:40PM
02:45PM
May-28-24 02:57PM
May-22-24 08:00AM
May-21-24 02:00PM
Huntington Ingalls Industries, Inc. engages in the shipbuilding business. It operates through the following business segments: Ingalls, Newport News, and Mission Technologies. The Ingalls segment designs and constructs non-nuclear ships, including amphibious assault ships, expeditionary warfare ships, surface combatants, and national security cutters (NSC). The Newport News segment designs and builds nuclear-powered aircraft carriers and submarines, and the refueling and overhaul and the inactivation of nuclear-powered aircraft carriers. The Mission Technologies segment includes business groups focused on high-end information technology (IT) and mission-based solutions for DoD, intelligence, and federal civilian customers, life-cycle sustainment services to the U.S. Navy fleet and other maritime customers, unmanned, autonomous systems, and nuclear management and operations and environmental management services for the Department of Energy (DoE), DoD, state and local governments, and private sector companies. The company was founded on August 4, 2010, and is headquartered in Newport News, VA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Wyatt D R Corp VP & Treasurer Nov 11 '24 Sale 205.24 400 82,096 19,627 Nov 12 04:18 PM Wyatt D R Officer Nov 11 '24 Proposed Sale 205.24 400 82,096 Nov 12 10:09 AM Jimenez Frank R Director Nov 05 '24 Buy 188.91 550 103,900 550 Nov 05 04:18 PM Hughes Edmond E. Jr. Ex VP & Chief HR Officer May 20 '24 Sale 256.07 1,500 384,102 8,135 May 21 09:49 AM Boykin Jennifer R. Ex VP, President NNS May 10 '24 Sale 252.03 1,043 262,837 0 May 13 04:58 PM Green Edgar A III Ex VP, Pres. HII Mission Tech Mar 01 '24 Sale 290.75 3,603 1,047,572 7,461 Mar 04 07:12 PM Schuck Nicolas G Corp VP, Controller & CAO Mar 01 '24 Sale 291.28 1,293 376,742 2,250 Mar 04 07:06 PM Wyatt D R Corp VP & Treasurer Feb 21 '24 Sale 288.56 500 144,282 18,600 Feb 23 05:02 PM Boykin Jennifer R. Ex VP, President NNS Feb 09 '24 Sale 272.31 2,176 592,556 6,877 Feb 12 04:22 PM Wyatt D R Corp VP & Treasurer Feb 05 '24 Sale 263.69 900 237,320 19,100 Feb 06 05:51 PM
Index NDX, S&P 500
P/E 22.46
EPS (ttm) 3.65
Insider Own 3.15%
Shs Outstand 455.34M
Perf Week -1.11%
Market Cap 37.46B
Forward P/E 17.50
EPS next Y 4.69
Insider Trans -0.20%
Shs Float 442.47M
Perf Month -8.16%
Income 1.68B
PEG 2.19
EPS next Q 1.26
Inst Own 80.94%
Short Float 1.87%
Perf Quarter -3.28%
Sales 19.56B
P/S 1.92
EPS this Y 9.34%
Inst Trans 2.68%
Short Ratio 2.64
Perf Half Y 3.37%
Book/sh 18.20
P/B 4.50
EPS next Y 9.06%
ROA 5.06%
Short Interest 8.28M
Perf Year 11.75%
Cash/sh 7.81
P/C 10.50
EPS next 5Y 10.24%
ROE 21.70%
52W Range 66.39 - 94.55
Perf YTD 6.05%
Dividend Est. 0.13 (0.15%)
P/FCF 22.10
EPS past 5Y -2.54%
ROI 9.34%
52W High -13.27%
Beta 1.33
Dividend TTM 0.12 (0.15%)
Quick Ratio 0.94
Sales past 5Y 4.14%
Gross Margin 41.42%
52W Low 23.51%
ATR (14) 2.19
Dividend Ex-Date Oct 18, 2024
Current Ratio 1.19
EPS Y/Y TTM 8.62%
Oper. Margin 14.56%
RSI (14) 37.03
Volatility 2.62% 2.61%
Employees 51000
Debt/Eq 1.29
Sales Y/Y TTM 1.42%
Profit Margin 8.56%
Recom 1.90
Target Price 96.94
Option/Short Yes / Yes
LT Debt/Eq 1.16
EPS Q/Q 25.06%
Payout 3.97%
Rel Volume 1.60
Prev Close 84.90
Sales Surprise -0.11%
EPS Surprise 8.31%
Sales Q/Q 0.85%
Earnings Oct 30 BMO
Avg Volume 3.14M
Price 82.00
SMA20 -4.02%
SMA50 -7.27%
SMA200 -3.34%
Trades
Volume 4,930,589
Change -3.42%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-26-24 Downgrade
UBS
Neutral → Sell
$84 → $74
Sep-18-24 Upgrade
BTIG Research
Neutral → Buy
$100
Sep-09-24 Initiated
JP Morgan
Neutral
$90
Aug-06-24 Initiated
Stifel
Buy
$100
May-30-24 Initiated
Goldman
Neutral
$87
Feb-15-24 Initiated
HSBC Securities
Buy
$100
Feb-12-24 Upgrade
UBS
Sell → Neutral
$66 → $88
Nov-30-23 Initiated
Jefferies
Hold
$80
Nov-27-23 Downgrade
UBS
Neutral → Sell
$86 → $66
Sep-19-23 Initiated
Citigroup
Buy
$82
Aug-25-23 Initiated
Argus
Buy
$80
Aug-16-23 Initiated
Wells Fargo
Overweight
$90
Jul-31-23 Initiated
BofA Securities
Neutral
$82
Jun-27-23 Initiated
Morgan Stanley
Equal-Weight
$76
May-16-23 Initiated
Oppenheimer
Outperform
$97
Apr-26-23 Initiated
UBS
Neutral
$86
Apr-19-23 Initiated
Piper Sandler
Overweight
$95
Apr-10-23 Initiated
BTIG Research
Neutral
Mar-13-23 Initiated
Evercore ISI
Outperform
$90
Feb-17-23 Initiated
Mizuho
Buy
$90
Show Previous Ratings
Nov-21-24 04:54PM
06:00AM
Nov-18-24 08:00AM
Nov-13-24 08:00AM
Nov-12-24 08:13PM
10:00AM
Loading…
10:00AM
Nov-11-24 06:00AM
Nov-07-24 09:31PM
04:58PM
08:00AM
Nov-03-24 01:37PM
Oct-31-24 06:57AM
02:58AM
Oct-30-24 06:20AM
Oct-24-24 12:16PM
12:10PM
Loading…
Oct-21-24 12:10PM
12:10PM
Oct-18-24 02:30PM
09:20AM
Oct-17-24 09:00AM
Oct-16-24 12:38PM
Oct-14-24 09:00AM
Oct-09-24 09:00AM
Oct-08-24 08:46AM
(Investor's Business Daily)
08:00AM
Oct-07-24 09:00AM
02:30AM
Oct-06-24 01:24PM
Sep-30-24 10:35AM
(The Wall Street Journal)
Sep-27-24 04:32PM
09:00AM
Loading…
Sep-26-24 09:00AM
Sep-24-24 06:40PM
09:00AM
Sep-19-24 09:00AM
Sep-18-24 04:50PM
Sep-12-24 09:40PM
05:02PM
Aug-26-24 09:00AM
Aug-21-24 09:00AM
Aug-20-24 08:30AM
Aug-19-24 10:00AM
Aug-14-24 09:50AM
Aug-02-24 01:37PM
Jul-31-24 06:20AM
Jul-25-24 08:45AM
Jul-21-24 10:00AM
Jul-18-24 03:26AM
Jul-15-24 12:15PM
Jul-13-24 08:45PM
Jul-12-24 06:54AM
Jul-11-24 02:01PM
Jul-10-24 10:15AM
Jul-08-24 08:00AM
Jul-02-24 11:56AM
Jun-28-24 08:28PM
08:26PM
Jun-26-24 12:32PM
09:52AM
Jun-25-24 12:46PM
Jun-24-24 11:20AM
10:00AM
Jun-20-24 10:47AM
Jun-17-24 12:12PM
Jun-10-24 04:06PM
Jun-07-24 12:40PM
Jun-04-24 09:00AM
May-30-24 10:00AM
May-28-24 06:45AM
May-26-24 09:58PM
May-22-24 06:39PM
09:00AM
May-21-24 09:00AM
May-15-24 12:08PM
May-14-24 09:00AM
May-13-24 02:25PM
May-10-24 09:00AM
May-07-24 08:19AM
May-06-24 08:05AM
06:58AM
May-05-24 08:00AM
May-03-24 09:53AM
May-02-24 04:05PM
May-01-24 09:30AM
Apr-30-24 04:41PM
04:29PM
12:56PM
12:37PM
12:21PM
(The Wall Street Journal)
10:54AM
10:32AM
(The Wall Street Journal)
09:30AM
07:30AM
06:20AM
Apr-29-24 09:00AM
Apr-28-24 08:00AM
Apr-25-24 09:13PM
Apr-24-24 11:34AM
09:30AM
Apr-23-24 05:50PM
01:38PM
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment provides scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment specializes in providing medical devices, consumables, services, and digital solutions. The Pharmaceutical Diagnostics segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company's history roots back to the year 1892 and it was incorporated on May 16, 2022 and is headquartered in Chicago, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Rott Roland CEO, Imaging Nov 05 '24 Option Exercise 40.40 13,275 536,310 37,573 Nov 06 05:53 PM Rott Roland CEO, Imaging Nov 06 '24 Sale 86.48 3,577 309,339 24,298 Nov 06 05:53 PM Roland Rott Officer Nov 06 '24 Proposed Sale 86.48 3,577 309,330 Nov 06 05:45 PM Philip Rackliffe Officer Nov 05 '24 Proposed Sale 87.63 900 78,870 Nov 05 05:22 PM Rackliffe Philip CEO, AVS Nov 05 '24 Sale 87.63 900 78,867 12,715 Nov 05 04:06 PM Stacherski Kenneth R. Ch. Supply Chain & Serv. Ofc. Aug 14 '24 Sale 83.22 19,008 1,581,846 38,541 Aug 15 04:45 PM Kenneth Stacherski Officer Aug 14 '24 Proposed Sale 82.74 19,008 1,572,774 Aug 14 05:57 PM Jan Makela Officer Aug 12 '24 Proposed Sale 83.20 33,096 2,753,587 Aug 12 04:58 PM Westrick Thomas J. CEO, Patient Care Solutions Aug 07 '24 Sale 80.78 2,750 222,145 17,509 Aug 07 06:18 PM Thomas Westrick Officer Aug 07 '24 Proposed Sale 80.78 2,750 222,146 Aug 07 05:30 PM Kass-Hout Taha Chief Technology Officer May 28 '24 Sale 78.70 3,300 259,710 67,300 May 29 04:05 PM Makela Jan CEO, Imaging May 15 '24 Option Exercise 74.35 66,955 4,978,229 130,303 May 15 07:15 PM Makela Jan CEO, Imaging May 13 '24 Option Exercise 63.51 20,227 1,284,617 83,575 May 15 07:15 PM Makela Jan CEO, Imaging May 15 '24 Sale 81.54 66,955 5,459,511 63,348 May 15 07:15 PM Makela Jan CEO, Imaging May 13 '24 Sale 81.57 20,227 1,649,916 63,348 May 15 07:15 PM Jimenez Frank R GC & Corporate Secretary May 01 '24 Buy 76.52 1,315 100,624 75,796 May 02 06:00 AM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite